BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 27720715)

  • 1. miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP.
    Jana S; Sengupta S; Biswas S; Chatterjee A; Roy H; Bhattacharyya A
    Biochem Biophys Res Commun; 2017 Jan; 482(1):126-133. PubMed ID: 27720715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
    Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
    Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation.
    Malakar P; Shilo A; Mogilevsky A; Stein I; Pikarsky E; Nevo Y; Benyamini H; Elgavish S; Zong X; Prasanth KV; Karni R
    Cancer Res; 2017 Mar; 77(5):1155-1167. PubMed ID: 27993818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression.
    Lee KM; Seo EC; Lee JH; Kim HJ; Hwangbo C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological Role and Aberrant Overexpression of Syntenin-1 in Cancer: Potential Role as a Biomarker and Therapeutic Target.
    Pintor-Romero VG; Hurtado-Ortega E; Nicolás-Morales ML; Gutiérrez-Torres M; Vences-Velázquez A; Ortuño-Pineda C; Espinoza-Rojo M; Navarro-Tito N; Cortés-Sarabia K
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA NEAT1 Inhibits miRNA-216b and Promotes Colorectal Cancer Progression by Indirectly Activating YY1.
    Zhu Y; Wang X; Zheng L; Li D; Liu Z; Teng L
    J Oncol; 2022; 2022():8130132. PubMed ID: 36262350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of inhibitor of apoptosis protein‑like protein‑2 on breast cancer cell proliferation.
    Xiang S; Zhu L; Zhang Z; Wang S; Cui R; Xiang M
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxic Breast Cancer Cell-Derived Exosomal SNHG1 Promotes Breast Cancer Growth and Angiogenesis via Regulating miR-216b-5p/JAK2 Axis.
    Dai G; Yang Y; Liu S; Liu H
    Cancer Manag Res; 2022; 14():123-133. PubMed ID: 35027847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-216b targets
    Liu T; Ye P; Ye Y; Han B
    Int J Biol Sci; 2021; 17(11):2970-2983. PubMed ID: 34345220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis.
    Zhu M; Wang Y; Wang F; Li L; Qiu X
    Cancer Cell Int; 2021 Jul; 21(1):384. PubMed ID: 34281530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiostrepton and miR-216b synergistically promote osteosarcoma cell cytotoxicity and apoptosis by targeting FoxM1.
    Cai X; Xiao W; Shen J; Lian H; Lu Y; Liu X; Gu J
    Oncol Lett; 2020 Dec; 20(6):391. PubMed ID: 33193851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of exosomal miR‑1273a increases cisplatin resistance of non‑small cell lung cancer by upregulating the expression of syndecan binding protein.
    Zhao X; Li M; Dai X; Yang Y; Peng Y; Xu C; Dai N; Wang D
    Oncol Rep; 2020 Nov; 44(5):2165-2173. PubMed ID: 32901857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential miRNAs for miRNA-Based Therapeutics in Breast Cancer.
    Wong JS; Cheah YK
    Noncoding RNA; 2020 Jul; 6(3):. PubMed ID: 32668603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDA-9/Syntenin/SDCBP: new insights into a unique multifunctional scaffold protein.
    Pradhan AK; Maji S; Das SK; Emdad L; Sarkar D; Fisher PB
    Cancer Metastasis Rev; 2020 Sep; 39(3):769-781. PubMed ID: 32410111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX9: The master regulator of cell fate in breast cancer.
    Jana S; Madhu Krishna B; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
    Biochem Pharmacol; 2020 Apr; 174():113789. PubMed ID: 31911091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico prediction of potential miRNA-disease association using an integrative bioinformatics approach based on kernel fusion.
    Guan NN; Wang CC; Zhang L; Huang L; Li JQ; Piao X
    J Cell Mol Med; 2020 Jan; 24(1):573-587. PubMed ID: 31747722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA DSCAM-AS1 downregulates miR-216b to promote the migration and invasion of colorectal adenocarcinoma cells.
    Liu F; Jia J; Sun L; Yu Q; Duan H; Jiao D; Gong Z; Zhu S; Jiang K; He Y; Chen L; Zhang Y; Sun H
    Onco Targets Ther; 2019; 12():6789-6795. PubMed ID: 31686837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
    Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine 5'-phosphate oxidase is correlated with human breast invasive ductal carcinoma development.
    Ren W; Guan W; Zhang J; Wang F; Xu G
    Aging (Albany NY); 2019 Apr; 11(7):2151-2176. PubMed ID: 30982780
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.